NEW YORK (PIX11) – The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression.
Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous, according to the FDA. The agency labeled the recall as a Class II, meaning the product has a low chance of causing significant injuries or death.
According to the FDA website, the Duloxetine delayed-release oral capsule was labeled and distributed by Breckenridge Pharmaceutical.
Duloxetine may also be recognized by other brand names found here.
For more information about the recall, click here.
